Lyell Immunopharma, Inc. (LYEL) Total assets 2020–2025
Lyell Immunopharma, Inc. (LYEL) total assets at each fiscal year-end, per SEC filings.
$340.1MFY2025 · since FY2020: $908.3M → $340.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $340.1M | -30.7% |
| FY2024 | $490.9M | -34.6% |
| FY2023 | $750.0M | -20.0% |
| FY2022 | $937.6M | -16.8% |
| FY2021 | $1.1B | +24.1% |
| FY2020 | $908.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice